Cargando…
Synergistic anticancer effects of bufalin and sorafenib by regulating apoptosis associated proteins
As one of the most recognized and well-known drugs for hepatocellular carcinoma (HCC), the antitumor effect of sorafenib against HCC remains to be improved. Bufalin has displayed an antitumor effect in HCC; however, whether the enhanced antitumor effect may be generated with their combined treatment...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983987/ https://www.ncbi.nlm.nih.gov/pubmed/29693132 http://dx.doi.org/10.3892/mmr.2018.8927 |